V
Vir Biotechnology
Brings together cutting-edge innovations with scientific expertise and management
At a glance
- Founded
- 2016
- Headquarters
- San Francisco, United States
- Listing
- IPO 2019
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Research & analysis
Latest news
Press, funding announcements and product moves mentioning Vir Biotechnology.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later7 investors entered at this stage
ARCH Venture Partners- OUOregon Health & Science University
SoftBank Vision Fund- AVAltitude Life Science Ventures
- APAlta Partners
- BFBill & Melinda Gates Foundation
8VC
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
86 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Vir Biotechnology was the backer or acquirer, 2017–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
5 deals across Vir Biotechnology's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Vir Biotechnology's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Vir Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vir Biotechnology on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.